The UK has one of the strongest and most productive life sciences sectors in the world, generating turnover of over £50 billion. There are nearly 5000 companies in the wider health life science sector (including non-manufacturing and service companies) in the UK. £4.21 billion was spent on pharmaceutical R&D in the UK in 2012, 25% of the total industrial R&D spend and 34% of total manufacturing industry R&D. Harriet Fear, Chief Executive at One Nucleus, shares her thoughts on the Cambridge/London life science and healthcare corridor.
https://international-pharma.com/wp-content/uploads/2015/06/The-Cambridge…pdf.pdf